Clinical Trial Update: Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 trial evaluating changes in the number of nerves in the skin at the tanezumab injection site in patients with osteoarthritis pain, ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Low Back Pain
• Osteoarthritis

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis Pain, Chronic Low Back Pain | Phase 1 | Status: COMPLETED